SRMS
Tyrosine-protein kinase Srms
Also known as: C20orf148, dJ697K14.1, PTK70, SRM, SRMS_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H3Y6
- Gene
- SRMS
- Ensembl
- ENSG00000125508
- Chromosome
- 20
- Canonical length
- 488 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Intermediate filaments,Actin filaments,Cytosol
OverviewNCBI Gene
Enables protein tyrosine kinase activity. Involved in peptidyl-tyrosine autophosphorylation and positive regulation of TORC1 signaling. Located in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
488 residues, UniProt reviewed canonical sequence.
>Q9H3Y6|SRMS
1 MEPFLRRRLA FLSFFWDKIW PAGGEPDHGT PGSLDPNTDP VPTLPAEPCS PFPQLFLALY
61 DFTARCGGEL SVRRGDRLCA LEEGGGYIFA RRLSGQPSAG LVPITHVAKA SPETLSDQPW
121 YFSGVSRTQA QQLLLSPPNE PGAFLIRPSE SSLGGYSLSV RAQAKVCHYR VSMAADGSLY
181 LQKGRLFPGL EELLTYYKAN WKLIQNPLLQ PCMPQKAPRQ DVWERPHSEF ALGRKLGEGY
241 FGEVWEGLWL GSLPVAIKVI KSANMKLTDL AKEIQTLKGL RHERLIRLHA VCSGGEPVYI
301 VTELMRKGNL QAFLGTPEGR ALRLPPLLGF ACQVAEGMSY LEEQRVVHRD LAARNVLVDD
361 GLACKVADFG LARLLKDDIY SPSSSSKIPV KWTAPEAANY RVFSQKSDVW SFGVLLHEVF
421 TYGQCPYEGM TNHETLQQIM RGYRLPRPAA CPAEVYVLML ECWRSSPEER PSFATLREKL
481 HAIHRCHPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SRMS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 2.1 nTPM
Expression across tissuesHPA
Tissue
- spleen: 2.1 nTPM
- stomach: 2.1 nTPM
- epididymis: 2 nTPM
- prostate: 1.5 nTPM
- colon: 1.2 nTPM
- breast: 1.1 nTPM
Single-cell type
- gastric chief cells: 20 nCPM
- goblet cells: 16 nCPM
- breast lactating cells: 12 nCPM
- epididymal principal cells: 10 nCPM
- foveolar cells: 9 nCPM
- mucous neck cells: 9 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 1.3 nTPM
- white matter: 1.3 nTPM
- cerebral cortex: 0.8 nTPM
- pons: 0.6 nTPM
- basal ganglia: 0.5 nTPM
- medulla oblongata: 0.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.52
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.01
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- cell surface receptor protein tyrosine kinase signaling pathway
- negative regulation of signal transduction
- peptidyl-tyrosine autophosphorylation
- peptidyl-tyrosine phosphorylation
- positive regulation of TORC1 signaling
Molecular functions
- ATP binding
- non-membrane spanning protein tyrosine kinase activity
- protein tyrosine kinase activity
- signaling receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- SH2 domain
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- SH3 domain
- Tyrosine-protein kinase, active site
- Protein kinase-like domain superfamily
- Protein kinase, ATP binding site
- Tyrosine-protein kinase, catalytic domain
- SH3-like domain superfamily
- SH2 domain superfamily
- Non-receptor tyrosine kinases involved in cell signaling
- SH2 domain
- Protein tyrosine and serine/threonine kinase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SRMS in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SRMS as an antibody target. Whether an autoantibody or antibody against SRMS could matter depends on whether native SRMS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SRMS is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SRMS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...